Aflibercept-Mrbb Suppliers & Bulk Manufacturers

Available Forms: Intravitreal injection (liquid solution)

Available Strengths: 2mg (0.05 mL of a 40 mg/mL solution)

Reference Brands: Eylea(US & EU); Ahzantive - biosimilar to biosimilar to Eylea

Category: Biosimilars

Aflibercept-mrbb is available in Intravitreal injection (liquid solution) and strengths such as 2mg (0.05 mL of a 40 mg/mL solution). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Aflibercept-mrbb is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Aflibercept-mrbb can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Ahzantive, a biosimilar of Eylea, is regulated in the EU and US, supported by dossiers demonstrating biosimilarity, safety, efficacy, and manufacturing quality in compliance with GMP and MDR standards. In the US, FDA approval involves extensive clinical validation, safety assessments, and comparability data. In the EU, CE marking certifies conformity with MDR standards for biosimilars. These products undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical results, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to affordable, effective ophthalmic biosimilars supporting eye disease management worldwide.